4//SEC Filing
Lin Patrick 4
Accession 0000897069-24-000236
CIK 0001533743other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 6:32 PM ET
Size
6.1 KB
Accession
0000897069-24-000236
Insider Transaction Report
Form 4
Lin Patrick
Chief Business - Strategy Off
Transactions
- Purchase
Common Stock
2024-02-01$2.40/sh+1,500$3,600→ 27,478 total - Purchase
Common Stock
2024-01-31$2.37/sh+2,500$5,925→ 25,978 total
Footnotes (1)
- [F1]Effective on January 22, 2024, Processa Pharmaceuticals, Inc. effected a 20 to 1 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
Documents
Issuer
Processa Pharmaceuticals, Inc.
CIK 0001533743
Entity typeother
Related Parties
1- filerCIK 0001799363
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 6:32 PM ET
- Size
- 6.1 KB